Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Patients with SATB2-associated syndrome exhibiting multiple odontomas.

Kikuiri T, Mishima H, Imura H, Suzuki S, Matsuzawa Y, Nakamura T, Fukumoto S, Yoshimura Y, Watanabe S, Kinoshita A, Yamada T, Shindoh M, Sugita Y, Maeda H, Yawaka Y, Mikoya T, Natsume N, Yoshiura KI.

Am J Med Genet A. 2018 Dec;176(12):2614-2622. doi: 10.1002/ajmg.a.40670. Epub 2018 Dec 21.

PMID:
30575289
2.

Oncolytic potential of an E4-deficient adenovirus that can recognize the stabilization of AU-rich element containing mRNA in cancer cells.

Yanagawa-Matsuda A, Mikawa Y, Habiba U, Kitamura T, Yasuda M, Towfik-Alam M, Kitagawa Y, Minowa K, Shindoh M, Higashino F.

Oncol Rep. 2019 Feb;41(2):954-960. doi: 10.3892/or.2018.6865. Epub 2018 Nov 12.

3.

HuR translocation to the cytoplasm of cancer cells in actin-independent manner.

Habiba U, Kuroshima T, Yanagawa-Matsuda A, Kitamura T, Chowdhury A, Jehung JP, Hossain E, Sano H, Kitagawa Y, Shindoh M, Higashino F.

Exp Cell Res. 2018 Aug 15;369(2):218-225. doi: 10.1016/j.yexcr.2018.05.021. Epub 2018 May 26.

4.

Adenovirus infection induces HuR relocalization to facilitate virus replication.

Jehung JP, Kitamura T, Yanagawa-Matsuda A, Kuroshima T, Towfik A, Yasuda M, Sano H, Kitagawa Y, Minowa K, Shindoh M, Higashino F.

Biochem Biophys Res Commun. 2018 Jan 8;495(2):1795-1800. doi: 10.1016/j.bbrc.2017.12.036. Epub 2017 Dec 7.

PMID:
29225167
5.

Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistance.

Hida K, Maishi N, Akiyama K, Ohmura-Kakutani H, Torii C, Ohga N, Osawa T, Kikuchi H, Morimoto H, Morimoto M, Shindoh M, Shinohara N, Hida Y.

Cancer Sci. 2017 Nov;108(11):2195-2203. doi: 10.1111/cas.13388. Epub 2017 Sep 17.

6.

18F-Fluoromisonidazole positron emission tomography (FMISO-PET) may reflect hypoxia and cell proliferation activity in oral squamous cell carcinoma.

Sato J, Kitagawa Y, Watanabe S, Asaka T, Ohga N, Hirata K, Okamoto S, Shiga T, Shindoh M, Kuge Y, Tamaki N.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Sep;124(3):261-270. doi: 10.1016/j.oooo.2017.05.506. Epub 2017 Jun 8.

PMID:
28734696
7.

ROS enhance angiogenic properties via regulation of NRF2 in tumor endothelial cells.

Hojo T, Maishi N, Towfik AM, Akiyama K, Ohga N, Shindoh M, Hida Y, Minowa K, Fujisawa T, Hida K.

Oncotarget. 2017 Jul 11;8(28):45484-45495. doi: 10.18632/oncotarget.17567.

8.

miR-145 promoted anoikis resistance in tumor endothelial cells.

Hida K, Kawamoto T, Maishi N, Morimoto M, Akiyama K, Ohga N, Shindoh M, Shinohara N, Hida Y.

J Biochem. 2017 Aug 1;162(2):81-84. doi: 10.1093/jb/mvx033.

PMID:
28510655
9.

Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.

Torii C, Hida Y, Shindoh M, Akiyama K, Ohga N, Maishi N, Ohiro Y, Ono M, Totsuka Y, Kitagawa Y, Tei K, Sato Y, Hida K.

Anticancer Res. 2017 Mar;37(3):1219-1225.

PMID:
28314285
10.

ALDH1 and podoplanin expression patterns predict the risk of malignant transformation in oral leukoplakia.

Habiba U, Hida K, Kitamura T, Matsuda AY, Higashino F, Ito YM, Ohiro Y, Totsuka Y, Shindoh M.

Oncol Lett. 2017 Jan;13(1):321-328. doi: 10.3892/ol.2016.5379. Epub 2016 Nov 10.

11.

HuR and podoplanin expression is associated with a high risk of malignant transformation in patients with oral preneoplastic lesions.

Habiba U, Kitamura T, Yanagawa-Matsuda A, Higashino F, Hida K, Totsuka Y, Shindoh M.

Oncol Lett. 2016 Nov;12(5):3199-3207. Epub 2016 Aug 29.

12.

Tumor endothelial cells express high pentraxin 3 levels.

Hida K, Maishi N, Kawamoto T, Akiyama K, Ohga N, Hida Y, Yamada K, Hojo T, Kikuchi H, Sato M, Torii C, Shinohara N, Shindoh M.

Pathol Int. 2016 Dec;66(12):687-694. doi: 10.1111/pin.12474. Epub 2016 Nov 14.

PMID:
27862647
13.

Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan.

Maishi N, Ohba Y, Akiyama K, Ohga N, Hamada J, Nagao-Kitamoto H, Alam MT, Yamamoto K, Kawamoto T, Inoue N, Taketomi A, Shindoh M, Hida Y, Hida K.

Sci Rep. 2016 Jun 13;6:28039. doi: 10.1038/srep28039.

14.

Receptor activator of NF-κB ligand induces cell adhesion and integrin α2 expression via NF-κB in head and neck cancers.

Yamada T, Tsuda M, Wagatsuma T, Fujioka Y, Fujioka M, Satoh AO, Horiuchi K, Nishide S, Nanbo A, Totsuka Y, Haga H, Tanaka S, Shindoh M, Ohba Y.

Sci Rep. 2016 Mar 24;6:23545. doi: 10.1038/srep23545.

15.

CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.

Yamada K, Maishi N, Akiyama K, Towfik Alam M, Ohga N, Kawamoto T, Shindoh M, Takahashi N, Kamiyama T, Hida Y, Taketomi A, Hida K.

Int J Cancer. 2015 Dec 15;137(12):2825-36. doi: 10.1002/ijc.29655. Epub 2015 Jul 2.

16.

Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel.

Akiyama K, Maishi N, Ohga N, Hida Y, Ohba Y, Alam MT, Kawamoto T, Ohmura H, Yamada K, Torii C, Shindoh M, Hida K.

Am J Pathol. 2015 Feb;185(2):572-80. doi: 10.1016/j.ajpath.2014.10.017. Epub 2014 Dec 8.

PMID:
25498238
17.

Identification of tumor endothelial cells with high aldehyde dehydrogenase activity and a highly angiogenic phenotype.

Ohmura-Kakutani H, Akiyama K, Maishi N, Ohga N, Hida Y, Kawamoto T, Iida J, Shindoh M, Tsuchiya K, Shinohara N, Hida K.

PLoS One. 2014 Dec 1;9(12):e113910. doi: 10.1371/journal.pone.0113910. eCollection 2014.

18.

Anti-BP180-type mucous membrane pemphigoid: report of two cases.

Wada M, Sato J, Shindoh M, Ujiie H, Natsuga K, Nishie W, Shimizu H, Kitagawa Y.

Odontology. 2016 Jan;104(1):114-8. doi: 10.1007/s10266-014-0181-2. Epub 2014 Oct 30.

PMID:
25355555
19.

Suprabasin as a novel tumor endothelial cell marker.

Alam MT, Nagao-Kitamoto H, Ohga N, Akiyama K, Maishi N, Kawamoto T, Shinohara N, Taketomi A, Shindoh M, Hida Y, Hida K.

Cancer Sci. 2014 Dec;105(12):1533-40. doi: 10.1111/cas.12549. Epub 2014 Nov 5.

20.

Filamin acts as a key regulator in epithelial defence against transformed cells.

Kajita M, Sugimura K, Ohoka A, Burden J, Suganuma H, Ikegawa M, Shimada T, Kitamura T, Shindoh M, Ishikawa S, Yamamoto S, Saitoh S, Yako Y, Takahashi R, Okajima T, Kikuta J, Maijima Y, Ishii M, Tada M, Fujita Y.

Nat Commun. 2014 Jul 31;5:4428. doi: 10.1038/ncomms5428.

21.

Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.

Sato J, Kitagawa Y, Yamazaki Y, Hata H, Asaka T, Miyakoshi M, Okamoto S, Shiga T, Shindoh M, Kuge Y, Tamaki N.

Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2031-41. doi: 10.1007/s00259-014-2810-y. Epub 2014 May 28.

PMID:
24867258
22.

Cytoplasmic expression of HuR may be a valuable diagnostic tool for determining the potential for malignant transformation of oral verrucous borderline lesions.

Habiba U, Kitamura T, Yanagawa-Matsuda A, Hida K, Higashino F, Ohiro Y, Totsuka Y, Shindoh M.

Oncol Rep. 2014 Apr;31(4):1547-54. doi: 10.3892/or.2014.3017. Epub 2014 Feb 10.

23.

pp32r1 controls the decay of the RNA-binding protein HuR.

Imamachi K, Higashino F, Kitamura T, Kakuguchi W, Yanagawa-Matsuda A, Ishikawa M, Kitagawa Y, Totsuka Y, Shindoh M.

Oncol Rep. 2014 Mar;31(3):1103-8. doi: 10.3892/or.2013.2956. Epub 2013 Dec 31.

24.

Hypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironment.

Kondoh M, Ohga N, Akiyama K, Hida Y, Maishi N, Towfik AM, Inoue N, Shindoh M, Hida K.

PLoS One. 2013 Nov 15;8(11):e80349. doi: 10.1371/journal.pone.0080349. eCollection 2013.

25.

Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis.

Osawa T, Ohga N, Akiyama K, Hida Y, Kitayama K, Kawamoto T, Yamamoto K, Maishi N, Kondoh M, Onodera Y, Fujie M, Shinohara N, Nonomura K, Shindoh M, Hida K.

Br J Cancer. 2013 Oct 15;109(8):2237-47. doi: 10.1038/bjc.2013.535. Epub 2013 Sep 17.

26.

18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinoma.

Sato J, Kitagawa Y, Yamazaki Y, Hata H, Okamoto S, Shiga T, Shindoh M, Kuge Y, Tamaki N.

J Nucl Med. 2013 Jul;54(7):1060-5. doi: 10.2967/jnumed.112.114355. Epub 2013 May 22.

27.

Expression of parathyroid hormone-related protein confers malignant potential to mucoepidermoid carcinoma.

Nagamine K, Kitamura T, Yanagawa-Matsuda A, Ohiro Y, Tei K, Hida K, Higashino F, Totsuka Y, Shindoh M.

Oncol Rep. 2013 Jun;29(6):2114-8. doi: 10.3892/or.2013.2393. Epub 2013 Apr 8.

28.

RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer.

Sato K, Lee JW, Sakamoto K, Iimura T, Kayamori K, Yasuda H, Shindoh M, Ito M, Omura K, Yamaguchi A.

Am J Pathol. 2013 May;182(5):1890-9. doi: 10.1016/j.ajpath.2013.01.038. Epub 2013 Mar 15.

PMID:
23499553
29.

The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma.

Akiyama K, Ohga N, Maishi N, Hida Y, Kitayama K, Kawamoto T, Osawa T, Suzuki Y, Shinohara N, Nonomura K, Shindoh M, Hida K.

Pathol Int. 2013 Jan;63(1):37-44. doi: 10.1111/pin.12031.

PMID:
23356224
30.

E1A expression might be controlled by miR-214 in cells with low adenovirus productivity.

Yanagawa-Matsuda A, Kitamura T, Higashino F, Yamano S, Totsuka Y, Shindoh M.

Virus Res. 2012 Dec;170(1-2):85-90. doi: 10.1016/j.virusres.2012.09.001. Epub 2012 Sep 11.

PMID:
22982546
31.

Increased telomerase activity and hTERT expression in human salivary gland carcinomas.

Shigeishi H, Sugiyama M, Tahara H, Ono S, Kumar Bhawal U, Okura M, Kogo M, Shinohara M, Shindoh M, Shintani S, Hamakawa H, Takata T, Kamata N.

Oncol Lett. 2011 Sep 1;2(5):845-850. Epub 2011 Jul 5.

32.

CXCR7: a novel tumor endothelial marker in renal cell carcinoma.

Maishi N, Ohga N, Hida Y, Akiyama K, Kitayama K, Osawa T, Onodera Y, Shinohara N, Nonomura K, Shindoh M, Hida K.

Pathol Int. 2012 May;62(5):309-17. doi: 10.1111/j.1440-1827.2012.02792.x. Epub 2012 Feb 21.

PMID:
22524658
33.

Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis.

Kawamoto T, Ohga N, Akiyama K, Hirata N, Kitahara S, Maishi N, Osawa T, Yamamoto K, Kondoh M, Shindoh M, Hida Y, Hida K.

PLoS One. 2012;7(3):e34045. doi: 10.1371/journal.pone.0034045. Epub 2012 Mar 30.

34.

Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner.

Osawa T, Ohga N, Hida Y, Kitayama K, Akiyama K, Onodera Y, Fujie M, Shinohara N, Shindoh M, Nonomura K, Hida K.

Cancer Sci. 2012 Jun;103(6):1038-44. doi: 10.1111/j.1349-7006.2012.02261.x. Epub 2012 Apr 17.

35.

Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells.

Yamamoto K, Ohga N, Hida Y, Maishi N, Kawamoto T, Kitayama K, Akiyama K, Osawa T, Kondoh M, Matsuda K, Onodera Y, Fujie M, Kaga K, Hirano S, Shinohara N, Shindoh M, Hida K.

Br J Cancer. 2012 Mar 13;106(6):1214-23. doi: 10.1038/bjc.2012.59. Epub 2012 Feb 28.

36.

Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment.

Akiyama K, Ohga N, Hida Y, Kawamoto T, Sadamoto Y, Ishikawa S, Maishi N, Akino T, Kondoh M, Matsuda A, Inoue N, Shindoh M, Hida K.

Am J Pathol. 2012 Mar;180(3):1283-93. doi: 10.1016/j.ajpath.2011.11.029. Epub 2012 Jan 13.

PMID:
22245726
37.

Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high- and low-metastatic tumors.

Ohga N, Ishikawa S, Maishi N, Akiyama K, Hida Y, Kawamoto T, Sadamoto Y, Osawa T, Yamamoto K, Kondoh M, Ohmura H, Shinohara N, Nonomura K, Shindoh M, Hida K.

Am J Pathol. 2012 Mar;180(3):1294-307. doi: 10.1016/j.ajpath.2011.11.035. Epub 2012 Jan 12.

PMID:
22245217
38.

Altered angiogenesis in the tumor microenvironment.

Hida K, Kawamoto T, Ohga N, Akiyama K, Hida Y, Shindoh M.

Pathol Int. 2011 Nov;61(11):630-7. doi: 10.1111/j.1440-1827.2011.02726.x. Epub 2011 Oct 10. Review.

PMID:
22029673
39.

RANKL expression specifically observed in vivo promotes epithelial mesenchymal transition and tumor progression.

Yamada T, Tsuda M, Takahashi T, Totsuka Y, Shindoh M, Ohba Y.

Am J Pathol. 2011 Jun;178(6):2845-56. doi: 10.1016/j.ajpath.2011.02.003. Epub 2011 May 10.

40.

Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells.

Muraki C, Ohga N, Hida Y, Nishihara H, Kato Y, Tsuchiya K, Matsuda K, Totsuka Y, Shindoh M, Hida K.

Int J Cancer. 2012 Jan 1;130(1):59-70. doi: 10.1002/ijc.25976. Epub 2011 Apr 20.

41.

Viral-mediated stabilization of AU-rich element containing mRNA contributes to cell transformation.

Kuroshima T, Aoyagi M, Yasuda M, Kitamura T, Jehung JP, Ishikawa M, Kitagawa Y, Totsuka Y, Shindoh M, Higashino F.

Oncogene. 2011 Jun 30;30(26):2912-20. doi: 10.1038/onc.2011.14. Epub 2011 Feb 14.

42.

HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium.

Kurosu T, Ohga N, Hida Y, Maishi N, Akiyama K, Kakuguchi W, Kuroshima T, Kondo M, Akino T, Totsuka Y, Shindoh M, Higashino F, Hida K.

Br J Cancer. 2011 Mar 1;104(5):819-29. doi: 10.1038/bjc.2011.20. Epub 2011 Feb 1.

43.

Phenotype of tumor lymphatic vessels is a prognostic factor in human tongue squamous cell carcinoma.

Nitta Y, Hida K, Kitamura T, Higashino F, Ohga N, Fukushima K, Shindoh M.

Oncol Lett. 2011 Jan;2(1):79-83. Epub 2010 Nov 8.

44.

A multiple primary carcinoma consisting of leukoplakia and SCC: a case report with p53 mutation analysis.

Hassan NM, Tada M, Shindoh M, Hamada J, Kashiwazaki H, Shimo T, Ashikaga Y, Yamazaki Y, Sasaki A, Moriuchi T, Inoue N.

Anticancer Res. 2010 Nov;30(11):4773-8.

PMID:
21115940
45.

Increased expression of tenascin-x in thoracic and abdominal aortic aneurysm tissues.

Satoh K, Tsukamoto M, Shindoh M, Totsuka Y, Oda T, Matsumoto K.

Biol Pharm Bull. 2010;33(11):1898-902.

46.

Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization.

Tsuchiya K, Hida K, Hida Y, Muraki C, Ohga N, Akino T, Kondo T, Miseki T, Nakagawa K, Shindoh M, Harabayashi T, Shinohara N, Nonomura K, Kobayashi M.

Int J Oncol. 2010 Jun;36(6):1379-86.

PMID:
20428760
47.

HuR knockdown changes the oncogenic potential of oral cancer cells.

Kakuguchi W, Kitamura T, Kuroshima T, Ishikawa M, Kitagawa Y, Totsuka Y, Shindoh M, Higashino F.

Mol Cancer Res. 2010 Apr;8(4):520-8. doi: 10.1158/1541-7786.MCR-09-0367. Epub 2010 Mar 23.

48.

Isolated tumor endothelial cells maintain specific character during long-term culture.

Matsuda K, Ohga N, Hida Y, Muraki C, Tsuchiya K, Kurosu T, Akino T, Shih SC, Totsuka Y, Klagsbrun M, Shindoh M, Hida K.

Biochem Biophys Res Commun. 2010 Apr 16;394(4):947-54. doi: 10.1016/j.bbrc.2010.03.089. Epub 2010 Mar 17.

PMID:
20302845
49.

De novo mutation in the DSPP gene associated with dentinogenesis imperfecta type II in a Japanese family.

Kida M, Tsutsumi T, Shindoh M, Ikeda H, Ariga T.

Eur J Oral Sci. 2009 Dec;117(6):691-4. doi: 10.1111/j.1600-0722.2009.00683.x.

PMID:
20121932
50.

Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors.

Akino T, Hida K, Hida Y, Tsuchiya K, Freedman D, Muraki C, Ohga N, Matsuda K, Akiyama K, Harabayashi T, Shinohara N, Nonomura K, Klagsbrun M, Shindoh M.

Am J Pathol. 2009 Dec;175(6):2657-67. doi: 10.2353/ajpath.2009.090202. Epub 2009 Oct 29.

Supplemental Content

Loading ...
Support Center